Scope of clinical research and clinical trials in India

According to a recent global survey India is the second most preferred destination for outsourcing clinical trials and clinical research services second to China with Russia being at third place. India has the advantage because of large patient pool, faster enrollment, and low cost.

Already big pharma MNC's like Eli Lilly, Aventis, Novartis, AstraZeneca and Pfizer, Johnson & Johnson, GSK, Merck, Amgen, Eisai and Bristol-Myers Squibb are conducting clinical trials in India.

There are about 300 domestic companies and 100 multinationals doing clinical trials in India

Students of pharmacy, life-sciences and even doctors are looking at clinical research as a career option, as companies are recruiting even trainees at salaries of about Rs 2.5 lakh per annum.

Novartis has recently opened their Clinical research Unit at Hyderabad which in future may employ 5000 professionals.

Paraxel International and Genzyne have also opened new centers at Hyderabad and Bangalore respectively.

Domestic Indian companies are also expanding their clinical researc and data management domains with acquisitions and new centerts.